Robert W Georgantas, Iii

Title: The Innovations of Robert W Georgantas, III

Introduction

Robert W Georgantas, III is an accomplished inventor based in Broomfield, CO (US). He has made significant contributions to the field of medical technology, particularly in predicting patient outcomes. With a total of 2 patents, his work has the potential to impact healthcare practices significantly.

Latest Patents

One of his latest patents is a method for predicting the risk of unfavorable outcomes, such as COVID-19 hospitalization, based on clinical characteristics and basic laboratory findings. This innovative method involves obtaining attributes from a patient's electronic health record, including findings at admission, basic patient characteristics, and laboratory data. These attributes are then supplied to a classifier implemented in a programmed computer, which is trained to predict the risk of unfavorable outcomes. The classifier is designed as a hierarchical combination of an initial binary classifier that stratifies patients into high or low-risk groups, along with child classifiers that further classify patients into lowest or highest risk groups. This structured approach enhances the accuracy of risk predictions, ultimately aiding healthcare providers in making informed decisions.

Career Highlights

Robert currently works at Biodesix, Inc., where he continues to develop innovative solutions in the medical field. His expertise in predictive modeling and data analysis has positioned him as a valuable asset to the company.

Collaborations

Throughout his career, Robert has collaborated with notable colleagues, including Thomas Campbell and Heinrich Röder. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Robert W Georgantas, III exemplifies the spirit of innovation in the medical technology sector. His contributions through patents and collaborations highlight the importance of predictive analytics in improving patient care.